What This Means
This research systematically reviewed 23 published studies examining sexual health outcomes for transmasculine individuals who underwent metoidioplasty, a type of genital gender-affirming surgery that uses existing genital tissue to create a phallus. The researchers searched multiple medical databases and evaluated outcomes including arousal, sensation, orgasm, erections, penetrative sex, and overall sexual satisfaction. They found that most sexual health outcomes were generally positive: arousal, sensation preservation, masturbation, and erectile function were all rated highly by patients in most studies, and overall sexual satisfaction ranged from moderate to high (53%–88%). However, the ability to engage in penetrative intercourse was low in most studies (0%–24%), making metoidioplasty most suitable for individuals who do not prioritize penetrative sex.
The research also identified important limitations in the existing evidence. All 23 studies used custom-made questionnaires rather than validated, standardized tools, and most studies did not primarily focus on sexual health. This inconsistency makes it difficult to compare results across studies and may explain why some outcomes, like orgasm (ranging from 66% to 100%) and erectile function (ranging from 20% to 94% depending on the study), varied so widely. The researchers noted that future studies need larger patient groups, clearer reporting of patient characteristics and surgical details, and consistent measurement tools.
This research suggests that metoidioplasty can lead to satisfying sexual health outcomes for many transmasculine individuals, particularly those who do not prioritize penetrative intercourse. The authors highlight that potential future interventions—such as medications like Viagra, penile injections, or prostheses—could be explored to improve outcomes. The findings are intended to support better-informed conversations between patients and surgeons when choosing among gender-affirming surgical options.